CK Life Sciences International Holdings (HKSE:00775) Additional Paid-In Capital : HK$3,110 Mil(As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is CK Life Sciences International Holdings Additional Paid-In Capital?

CK Life Sciences International Holdings's quarterly additional paid-in capital declined from Dec. 2022 (HK$3,186 Mil) to Jun. 2023 (HK$3,110 Mil) but then stayed the same from Jun. 2023 (HK$3,110 Mil) to Dec. 2023 (HK$3,110 Mil).

CK Life Sciences International Holdings's annual additional paid-in capital declined from Dec. 2021 (HK$3,542 Mil) to Dec. 2022 (HK$3,186 Mil) and declined from Dec. 2022 (HK$3,186 Mil) to Dec. 2023 (HK$3,110 Mil).

CK Life Sciences International Holdings Additional Paid-In Capital Historical Data

The historical data trend for CK Life Sciences International Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CK Life Sciences International Holdings Additional Paid-In Capital Chart

CK Life Sciences International Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

3,216.38

3,378.66

3,542.48

3,186.44

3,109.55

CK Life Sciences International Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															3,542.48	3,339.19	3,186.44	3,109.55	3,109.55

CK Life Sciences International Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

CK Life Sciences International Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of CK Life Sciences International Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

CK Life Sciences International Holdings (HKSE:00775) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (HKSE:00775) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

LSI:Germany

Address

2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG

Website

https://www.ck-lifesciences.com

CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.

CK Life Sciences International Holdings (HKSE:00775) Headlines

No Headlines